Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Focal-Onset Seizure”

209 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 209 results

Large-scale testing (Phase 3)Study completedNCT00151879
What this trial is testing

Safety and Tolerability of Intravenous SPM 927 as Replacement for Oral SPM 927 in Subjects With Partial Seizures

Who this might be right for
Epilepsies, Partial
UCB Pharma 160
Post-approval studies (Phase 4)Ended earlyNCT01546688
What this trial is testing

Evaluate the Safety and Tolerability and Explore the Efficacy of Zonisamide as add-on Therapy in Elderly Patients With Refractory Partial Seizures

Who this might be right for
Epilepsy
Eisai Limited 41
Not applicableEnded earlyNCT04839601
What this trial is testing

RNS System RESPONSE Study

Who this might be right for
EpilepsyPartial SeizureNeurostimulator; Complications+2 more
NeuroPace 9
Large-scale testing (Phase 3)Study completedNCT01463306
What this trial is testing

A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures

Who this might be right for
Epilepsy, Partial SeizuresEpilepsy, Primary Generalized Tonic-Clonic Seizures
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 605
Large-scale testing (Phase 3)Study completedNCT01389596
What this trial is testing

The Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Who this might be right for
Epilepsy, Partial Seizures
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 295
Large-scale testing (Phase 3)Study completedNCT03340064
What this trial is testing

Levetiracetam as Monotherapy or Adjunctive Treatment of Partial Seizures in Pediatric Epileptic Subjects Ranging From 1 Month to Less Than 4 Years of Age

Who this might be right for
Partial Seizures
UCB Japan Co. Ltd. 38
Large-scale testing (Phase 3)Study completedNCT00327717
What this trial is testing

Evaluating the Efficacy and Safety of Zonisamide in the Treatment of Partial Seizures

Who this might be right for
Partial Seizures
Eisai Inc. 240
Large-scale testing (Phase 3)Study completedNCT00848549
What this trial is testing

Assessing The Long-Term Safety And To Explore The Long-Term Efficacy Of Zonisamide As Monotherapy In Newly Diagnosed Partial Seizures

Who this might be right for
Epilepsy
Eisai Inc. 295
Large-scale testing (Phase 3)Ended earlyNCT00372528
What this trial is testing

An Open-Label Study Of Pregabalin In Subjects With Refractory Partial Seizures

Who this might be right for
Epilepsy
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 21
Testing effectiveness (Phase 2)Study completedNCT00800215
What this trial is testing

A Trial to Investigate the Safety, Tolerability and Pharmacokinetics of Intravenous SPM 927

Who this might be right for
Epilepsy
UCB Pharma 60
Post-approval studies (Phase 4)Ended earlyNCT05684978
What this trial is testing

Efficacy and Safety of Perampanel in the Treatment of Refractory Status Epilepticus

Who this might be right for
Refractory Status Epilepticus
Wayne State University 1
Not applicableActive Not RecruitingNCT05867160
What this trial is testing

Adjunctive Anti-seizure Medication (ASM) Real World Evidence (RWE) Study

Who this might be right for
Epilepsy
Aziende Chimiche Riunite Angelini Francesco S.p.A 300
Large-scale testing (Phase 3)Study completedNCT00152373
What this trial is testing

Double-blind, Placebo-controlled Study of Levetiracetam in Adults With POS

Who this might be right for
Epilepsy, Partial
UCB Pharma 192
Large-scale testing (Phase 3)Study completedNCT00136019
What this trial is testing

SPM 927 (400mg/Day and 600mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization

Who this might be right for
Epilepsy
UCB Pharma 400
Testing effectiveness (Phase 2)Study completedNCT00236873
What this trial is testing

The Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.

Who this might be right for
EpilepsyEpilepsies, PartialSeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 47
Testing effectiveness (Phase 2)Ended earlyNCT04153175
What this trial is testing

Study to Assess Intracerebroventricular (ICV) Delivery of CT-010 in Subjects With Focal Seizures, With Temporal Lobe Onset With or Without Secondary Generalization

Who this might be right for
Refractory Epilepsy
Cerebral Therapeutics LLC 30
Not applicableLooking for participantsNCT06716801
What this trial is testing

Real-world Clinical Response to Cenobamate Early add-on in France, Germany and Spain

Who this might be right for
Focal Epilepsy With and Without Secondary Generalization
Aziende Chimiche Riunite Angelini Francesco S.p.A 300
Not applicableStudy completedNCT00922987
What this trial is testing

Clinical Study With Lyrica In Patients Suffering From Epilepsy

Who this might be right for
NeuralgiaEpilepsy
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 286
Large-scale testing (Phase 3)Study completedNCT00988156
What this trial is testing

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Who this might be right for
Partial Epilepsy in Children and Adolescents
Bial - Portela C S.A. 304
Large-scale testing (Phase 3)Study completedNCT03083665
What this trial is testing

Evaluate the Efficacy and Safety of Brivaracetam in Study Participants (>=16 to 80 Years of Age) With Epilepsy

Who this might be right for
Partial Seizures With or Without Secondary GeneralizationEpilepsy
UCB Biopharma SRL 449
Load More Results